PAUL V. MAIER - 09 Jun 2021 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Director
Signature
/s/ Sophia Garnette, Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
09 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 14:11:17 UTC
Next filing
28 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +183,481 $0.000000 183,481 09 Jun 2021 Common Stock 183,481 $0.3900 Direct F1
transaction ISCO Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 09 Jun 2021 Common Stock 30,000 $0.3900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/09/2021.
F2 Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 09, 2022 or (ii) the date of the 2022 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control.